Total Artificial Heart Technology: Where Are We Now?

被引：0

作者：

Cole R.M. ^{[1
]}

Arabía F.A. ^{[2
]}

机构：

[1] Cardiology Division, Cedars-Sinai Smidt Heart Institute, 127 S. San Vicente Blvd, Los Angeles, 90048, CA

[2] Advanced Heart Programs, Banner/University of Arizona, Phoenix, AZ

来源：

Current Transplantation Reports | 2018年 / 5卷 / 4期

关键词：

Artificial heart; Biventricular failure; TAH; Total artificial heart;

D O I：

10.1007/s40472-018-0211-z

中图分类号：

学科分类号：

摘要：

Purpose of Review: The intended goal of this paper is to review current indications, available devices, and future directions of total artificial heart therapies. Throughout the paper, we sought to help clinicians identify appropriate patients who might be considered for total artificial heart therapy, highlighting the most current data regarding outcomes and adverse events. Recent Findings: The INTERMACS report on the total artificial heart has recently been published in the Journal of Heart and Lung Transplantation and represents the largest study to date on available TAH therapies. Notable findings include better outcomes at experienced centers, likely a result of appropriate patient selection, timing, and management of device therapy. Summary: There are multiple new types of total artificial hearts under development. Having learned from prior experience, and with increasing use and standardization of peri- and post-operative management, there is hope of ongoing success in improving care for those with advanced heart disease and biventricular failure with the use of this technology. © 2018, Springer Nature Switzerland AG.

引用

页码：315 / 318

页数：3

共 26 条

[1]

Cooley D.A., Liotta D., Hallman G.L., Bloodwell R.D., Leachman R.D., Milam J.D., Orthotopic cardiac prosthesis for two-staged cardiac replacement, Am J Cardiol, 24, 5, pp. 723-730, (1969)

[2]

Cooley D.A., Akutsu T., Norman J.C., Serrato M.A., Frazier O.H., Total artificial heart in two-staged cardiac transplantation, Cardiovasc Dis, 8, 3, pp. 305-319, (1981)

[3]

Jarvik R.K., The total artificial heart, Sci Am, 244, 1, pp. 74-80, (1981)

[4]

DeVries W.C., Anderson J.L., Joyce L.D., Anderson F.L., Hammond E.H., Jarvik R.K., Et al., Clinical use of the total artificial heart, N Engl J Med, 310, 5, pp. 273-278, (1984)

[5]

DeVries W.C., The permanent artificial heart. Four case reports, JAMA, 259, 6, pp. 849-859, (1988)

[6]

Copeland J.G., Levinson M.M., Smith R., Icenogle T.B., Vaughn C., Cheng K., Et al., The total artificial heart as a bridge to transplantation. A report of two cases, JAMA, 256, 21, pp. 2991-2995, (1986)

[7]

Carpentier A., Latremouille C., Cholley B., Smadja D.M., Roussel J.C., Boissier E., Et al., First clinical use of a bioprosthetic total artificial heart: report of two cases, Lancet, 386, 10003, pp. 1556-1563, (2015)

[8]

Kleinheyer M., Timms D.L., Greatrex N.A., Masuzawa T., Frazier O.H., Cohn W.E., Pulsatile operation of the BiVACOR TAH - motor design, control and hemodynamics, Conf Proc IEEE Eng Med Biol Soc, 2014, pp. 5659-5662, (2014)

[9]

Pelletier B., Spiliopoulos S., Finocchiaro T., Graef F., Kuipers K., Laumen M., Et al., System overview of the fully implantable destination therapy--ReinHeart-total artificial heart, Eur J Cardiothorac Surg, 47, 1, pp. 80-86, (2015)

[10]

Kobayashi M., Horvath D.J., Mielke N., Shiose A., Kuban B., Goodin M., Et al., Progress on the design and development of the continuous-flow total artificial heart, Artif Organs, 36, 8, pp. 705-713, (2012)

← 1 2 3 →